The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment
Abstract
Although dyskinesia is a frequent and important problem in Parkinson's disease (PD), a reliable assessment measure has not been thoroughly developed and tested. We modified the Obeso dyskinesia scale to creat an objective rating scale for dyskinesia assessment during activities of daily living. Thirteen physicians and 15 study coordinators involved in a clinical trial independently reviewed videotape segments of PD patients performing three tasks: walking, putting on a coat, and lifting a cup to the lips for drinking. Raters evaluated the severity of worst dyskinesia seen, the types of all dyskinesias seen, and the type of dyskinesia most associated with motoric disability. For all assessments, the total group showed statistically significant inter‐ and intrarater reliability. Physicians had a higher consistency than did coordinators, but for most measures the difference was not statistically significant. Physicians and coordinators found the scale easy to use and especially practical for rating dyskinesia severity and for identifying the most disabling dyskinesia. Dyskinesias can be assessed in clinical trials and warrant regular documentation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1976) · Medical Entomology and Zoology · Cited by 8,899
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Recent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
Core assessment program for intracerebral transplantations (CAPIT)
Langston, J. W., Widner, H., Goetz, C. G., Brooks, D., Fahn, S., Freeman, T., & Watts, R. (1992) · Movement Disorders · doi:10.1002/mds.870070103 · Cited by 1,008
Self-citationIrreversible motor impairment in young addicts ? ephedrone, manganism or both?
Sikk, K., Taba, P., Haldre, S., Bergquist, J., Nyholm, D., Zjablov, G., Asser, T., & Aquilonius, S.-M. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00818.x · Cited by 665
The “On–Off” Phenomenon in Parkinson’s Disease: Relation to Levodopa Absorption and Transport
Nutt, J. G., Woodward, W. R., Hammerstad, J. P., Carter, J. H., & Anderson, J. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402233100802 · Cited by 554
Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part II
Mouradian, M. M., Junecos, J. L., Fabbrini, G., Schlegel, J., Bartko, J. J., & Chase, T. N. (1988) · Annals of Neurology · doi:10.1002/ana.410240304 · Cited by 360
Fluctuations of disability in Parkinson's disease – clinical aspects
Marsden, C. D., Parkes, J. D., & Quinn, N. (1981) · Movement Disorders · doi:10.1016/b978-0-407-02295-9.50012-6 · Cited by 284
Duodenal delivery of levodopa for on‐off fluctuations in parkinsonism: Preliminary observations
Kurlan, R., Rubin, A. J., Miller, C. D., Rivera‐Calimlim, L., Clarke, A., & Shoulson, I. (1986) · Annals of Neurology · doi:10.1002/ana.410200213 · Cited by 140
Cited by
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa000827 · Cited by 1,514
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up
Rodriguez-Oroz, M. C., Obeso, J. A., Lang, A. E., Houeto, J.-L., Pollak, P., Rehncrona, S., Kulisevsky, J., Albanese, A., Volkmann, J., Hariz, M. I., et al. (2005) · Brain · doi:10.1093/brain/awh571 · Cited by 1,057
Self-citationCore assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD)
Defer, G.-L., Widner, H., Mari�, R.-M., R�my, P., Levivier, M., & Conference Participants: Conference Participants: G. L. Defer, M. (. (1999) · Movement Disorders · doi:10.1002/1531-8257(199907)14:4<572::aid-mds1005>3.0.co;2-c · Cited by 865
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
Nutt, J. G., Burchiel, K. J., Comella, C. L., Jankovic, J., Lang, A. E., Laws, E. R., Lozano, A. M., Penn, R. D., Simpson, R. K., Stacy, M., et al. (2003) · Neurology · doi:10.1212/wnl.60.1.69 · Cited by 824
Self-citationEffect of GPi pallidotomy on motor function in Parkinson's disease
Lozano, A. M., Lang, A. E., Galvez-Jimenez, N., Miyasaki, J., Duff, J., Hutchison, W. D., & Dostrovsky, J. O. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92404-3 · Cited by 603
Self-citationMoro, E., Lozano, A. M., Pollak, P., Agid, Y., Rehncrona, S., Volkmann, J., Kulisevsky, J., Obeso, J. A., Albanese, A., Hariz, M. I., et al. (2010) · Movement Disorders · doi:10.1002/mds.22735 · Cited by 468
Self-citationFabbrini, G., Brotchie, J. M., Grandas, F., Nomoto, M., & Goetz, C. G. (2007) · Movement Disorders · doi:10.1002/mds.21475 · Cited by 464
Self-citationPalfi, S., Gurruchaga, J. M., Ralph, G. S., Lepetit, H., Lavisse, S., Buttery, P. C., Watts, C., Miskin, J., Kelleher, M., Deeley, S., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61939-x · Cited by 450
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease
Nyholm, D., Nilsson Remahl, A. I. M., Dizdar, N., Constantinescu, R., Holmberg, B., Jansson, R., Aquilonius, S. M., & Askmark, H. (2005) · Neurology · doi:10.1212/01.wnl.0000149637.70961.4c · Cited by 432
Determinants of health-related quality of life in Parkinson’s disease: A systematic review
Soh, S.-E., Morris, M. E., & McGinley, J. L. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.012 · Cited by 386
Rating scales for dystonia: A multicenter assessment
Comella, C. L., Leurgans, S., Wuu, J., Stebbins, G. T., Chmura, T., & and The Dystonia Study Group (2003) · Movement Disorders · doi:10.1002/mds.10377 · Cited by 365
Self-citationCannabinoids reduce levodopa-induced dyskinesia in Parkinson’s disease: A pilot study
Sieradzan, K. A., Fox, S. H., Hill, M., Dick, J. P. R., Crossman, A. R., & Brotchie, J. M. (2001) · Neurology · doi:10.1212/wnl.57.11.2108 · Cited by 349
Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study
Katzenschlager, R. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.028761 · Cited by 318
Rochester, L., Hetherington, V., Jones, D., Nieuwboer, A., Willems, A.-M., Kwakkel, G., & Van Wegen, E. (2004) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2004.01.025 · Cited by 317
Randomized trial of the adenosine A 2A receptor antagonist istradefylline in advanced PD
Hauser, R. A., Hubble, J. P., Truong, D. D., & the Istradefylline US-001 Study Group (2003) · Neurology · doi:10.1212/01.wnl.0000081227.84197.0b · Cited by 300
Hauser, R. A., Friedlander, J., Zesiewicz, T. A., Adler, C. H., Seeberger, L. C., O'Brien, C. F., Molho, E. S., & Factor, S. A. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200003000-00003 · Cited by 300
Ondo, W. G., Tintner, R., Dat Voung, K., Lai, D., & Ringholz, G. (2005) · Movement Disorders · doi:10.1002/mds.20474 · Cited by 297
Randomized trial of safinamide add‐on to levodopa in Parkinson's disease with motor fluctuations
Borgohain, R., Szasz, J., Stanzione, P., Meshram, C., Bhatt, M., Chirilineau, D., Stocchi, F., Lucini, V., Giuliani, R., Forrest, E., et al. (2014) · Movement Disorders · doi:10.1002/mds.25751 · Cited by 293
Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation
Kumar, R., Lozano, A. M., Sime, E., Halket, E., & Lang, A. E. (1999) · Neurology · doi:10.1212/wnl.53.3.561 · Cited by 290
Self-citationCannabis for dyskinesia in Parkinson disease: A randomized double-blind crossover study
Carroll, C. B., Bain, P. G., Teare, L., Liu, X., Joint, C., Wroath, C., Parkin, S. G., Fox, P., Wright, D., Hobart, J., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000140288.48796.8e · Cited by 286
Katzenschlager, R., Hughes, A., Evans, A., Manson, A. J., Hoffman, M., Swinn, L., Watt, H., Bhatia, K., Quinn, N., & Lees, A. J. (2005) · Movement Disorders · doi:10.1002/mds.20276 · Cited by 286
Postural abnormalities to multidirectional stance perturbations in Parkinson's disease
Carpenter, M. G. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.021147 · Cited by 272
Long-Term Follow-up of Unilateral Pallidotomy in Advanced Parkinson's Disease
Fine, J., Duff, J., Chen, R., Hutchison, W., Lozano, A. M., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006083422304 · Cited by 266
Self-citationRochester, L., Hetherington, V., Jones, D., Nieuwboer, A., Willems, A.-M., Kwakkel, G., & Van Wegen, E. (2005) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2004.10.040 · Cited by 265
Testing Functional Performance in People With Parkinson Disease
Brusse, K. J., Zimdars, S., Zalewski, K. R., & Steffen, T. M. (2005) · Physical Therapy · doi:10.1093/ptj/85.2.134 · Cited by 252
Baker, K., Rochester, L., & Nieuwboer, A. (2007) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2007.07.026 · Cited by 191
Reliability between two observers using a protocol for diagnosing essential tremor
Louis, E. D., Ford, B., & Bismuth, B. (1998) · Movement Disorders · doi:10.1002/mds.870130215 · Cited by 150
An ambulatory dyskinesia monitor
Manson, A. J. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.2.196 · Cited by 79
Concurrent validity of accelerometry to measure gait in Parkinsons Disease
Lord, S., Rochester, L., Baker, K., & Nieuwboer, A. (2008) · Gait & Posture · doi:10.1016/j.gaitpost.2007.04.001 · Cited by 69
Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward
Evans, A. H., Lawrence, A. D., Cresswell, S. A., Katzenschlager, R., & Lees, A. J. (2010) · Movement Disorders · doi:10.1002/mds.22898 · Cited by 51
Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's disease
Lopane, G., Mellone, S., Chiari, L., Cortelli, P., Calandra‐Buonaura, G., & Contin, M. (2015) · Movement Disorders · doi:10.1002/mds.26313 · Cited by 43
Parkinson's disease: opportunities for novel therapeutics to reduce the problems of levodopa therapy
FOX, S., CHUANG, R., & BROTCHIE, J. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00923-0 · Cited by 39
Metadata
- Authors
- Goetz, C. G., Stebbins, G. T., Shale, H. M., Lang, A. E., Chernik, D. A., Chmura, T. A., Ahlskog, J. E., & Dorflinger, E. E.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 1994-01
- Volume
- 9
- Issue
- 4
- Pages
- 390-394
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2052510409
- Cited by
- 276
- References
- 10
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.